Wendy Lawrence of Totally discusses their Interim Results in which they reported growth on revenue, profit and raised the dividend

Episode 441,   Nov 15, 2021, 09:59 AM

Wendy Lawrence CEO of Totally #TLY discusses their Interim Results in which they reported 14% growth on revenue & gross profit plus they increased cash at bank and raised the dividend.

Wendy Lawrence CEO of Totally #TLY discusses their Interim Results in which they reported 14% growth on revenue & gross profit plus they increased cash at bank and raised the dividend.

Financial Highlights

·    Group turnover up 14% to £61.6 million (H1 2020: £54.1 million)

·    Gross profit up 14% to £11.6 million (H1 2020: £10.2 million)

·    Significant increase in EBITDA profit at £3.3 million (H1 2020: £2.3 million)

·    Profit before tax of £0.9 million (H1 2020: £0.1 million)

·    Strong cash position resulting in cash at bank of £18.3 million at 30 September 2021 (31 March 2021: £14.8 million)

·    Increase in proposed interim dividend to 0.5p per share (H1 2020: 0.25p) to be paid in February 2022

Operational Highlights

·    Assessed and treated more than one million patients during the reporting period

·    Urgent Care Division awarded extensions to 20 existing contracts across England, reflecting the quality of service and strength of relationships with NHS partners

·    Award and swift mobilisation of a new Urgent Treatment Centre contract at King's College London to provide continuity of service for a population of 700,000 people

·    Totally Healthcare awarded contract to support the reduction of waiting lists across six hospitals for the Saolta Group of Hospitals in the Republic of Ireland plus several other hospitals across the UK

About Totally

Totally plc is a leading healthcare service provider in the UK and Ireland, working in partnership with the NHS and other providers to deliver healthcare services through its divisions of Urgent Care, Planned Care and Insourcing.

Totally is committed to pursuing a progressive buy-and-build consolidation strategy within the fragmented healthcare market and looks to capitalise on the attractive opportunities that its disruptive service model offers, to generate value to shareholders.